Cartilage homeostasis in health and rheumatic diseases

被引:676
作者
Goldring, Mary B. [1 ]
Marcu, Kenneth B. [2 ,3 ]
机构
[1] Cornell Univ, Weill Coll Med, Hosp Special Surg, Div Res, New York, NY 10021 USA
[2] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA
[3] Univ Bologna, S Orsola Malpighi Univ Hosp, Ctr Ric Biomed Applicata, I-40138 Bologna, Italy
基金
美国国家卫生研究院;
关键词
HUMAN ARTICULAR CHONDROCYTES; NF-KAPPA-B; HUMAN OSTEOARTHRITIC CHONDROCYTES; MESENCHYMAL STEM-CELLS; TUMOR-NECROSIS-FACTOR; METALLOPROTEINASE GENE-EXPRESSION; PROLIFERATOR-ACTIVATED RECEPTOR; PROSTAGLANDIN-E SYNTHASE-1; ARTHRITIS SYNOVIAL TISSUE; HYPOXIA-INDUCIBLE FACTOR;
D O I
10.1186/ar2592
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
As the cellular component of articular cartilage, chondrocytes are responsible for maintaining in a low-turnover state the unique composition and organization of the matrix that was determined during embryonic and postnatal development. In joint diseases, cartilage homeostasis is disrupted by mechanisms that are driven by combinations of biological mediators that vary according to the disease process, including contributions from other joint tissues. In osteoarthritis (OA), biomechanical stimuli predominate with up-regulation of both catabolic and anabolic cytokines and recapitulation of developmental phenotypes, whereas in rheumatoid arthritis (RA), inflammation and catabolism drive cartilage loss. In vitro studies in chondrocytes have elucidated signaling pathways and transcription factors that orchestrate specific functions that promote cartilage damage in both OA and RA. Thus, understanding how the adult articular chondrocyte functions within its unique environment will aid in the development of rational strategies to protect cartilage from damage resulting from joint disease. This review will cover current knowledge about the specific cellular and biochemical mechanisms that regulate cartilage homeostasis and pathology.
引用
收藏
页数:16
相关论文
共 220 条
[1]
Osteoarthritis: Aging of matrix and cells - Going for a remedy [J].
Aigner, T. ;
Haag, J. ;
Martin, J. ;
Buckwalter, J. .
CURRENT DRUG TARGETS, 2007, 8 (02) :325-331
[2]
Functional genomics of osteoarthritis - On the way to evaluate disease hypotheses [J].
Aigner, T ;
Bartnik, E ;
Sohler, F ;
Zimmer, R .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2004, (427) :S138-S143
[3]
Apoptosis in ostemithritis [J].
Aigner, T ;
Kim, HA ;
Roach, HI .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2004, 30 (03) :639-+
[4]
SOX9 expression does not correlate with type II collagen expression in adult articular chondrocytes [J].
Aigner, T ;
Gebhard, PM ;
Schmid, E ;
Bau, B ;
Harley, V ;
Pöschl, E .
MATRIX BIOLOGY, 2003, 22 (04) :363-372
[5]
Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis [J].
Aigner, Thomas ;
Fundel, Katrin ;
Saas, Joachim ;
Gebhard, Pia M. ;
Haag, Jochen ;
Weiss, Tilo ;
Zien, Alexander ;
Obermayr, Franz ;
Zimmer, Ralf ;
Bartnik, Eckart .
ARTHRITIS AND RHEUMATISM, 2006, 54 (11) :3533-3544
[6]
Osteoarthritic changes in the biphasic mechanical properties of the chondrocyte pericellular matrix in articular cartilage [J].
Alexopoulos, LG ;
Williams, GM ;
Upton, ML ;
Setton, LA ;
Guilak, F .
JOURNAL OF BIOMECHANICS, 2005, 38 (03) :509-517
[7]
Animal models of osteoarthritis: lessons learned while seeking the 'Holy Grail' [J].
Ameye, Laurent G. ;
Young, Marian F. .
CURRENT OPINION IN RHEUMATOLOGY, 2006, 18 (05) :537-547
[8]
Key regulatory molecules of cartilage destruction in rheumatoid arthritis:: an in vitro study [J].
Andreas, Kristin ;
Luebke, Carsten ;
Haeupl, Thomas ;
Dehne, Tilo ;
Morawietz, Lars ;
Ringe, Jochen ;
Kaps, Christian ;
Sittinger, Michael .
ARTHRITIS RESEARCH & THERAPY, 2008, 10 (01)
[9]
Arend William P, 2008, Arthritis Rheum, V58, pS102, DOI 10.1002/art.23053
[10]
Aggrecanase-mediated cartilage degradation [J].
Arner, EC .
CURRENT OPINION IN PHARMACOLOGY, 2002, 2 (03) :322-329